Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy

Published:2020-12 Issue: Volume:19 Page:240-252
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Tzelepis Fanny,Birdi Harsimrat Kaur,Jirovec Anna,Boscardin Silvia,Tanese de Souza Christiano,Hooshyar Mohsen,Chen Andrew,Sutherland Keara,Parks Robin J.,Werier Joel,Diallo Jean-Simon^ORCID

Funder

Canadian Institute for Health Research

Terry Fox Research Institute

BioCanRx

Valerie’s Flutter Foundation

Canadian Cancer Society

Canadian Institutes of Health Research–Institute of Cancer Research

BioCanRx Travel Exchange Award

MITACS Accelerate Canadian Partnership in Immunotherapy Manufacturing Excellence PhD Internships

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference56 articles.

1. Tumor microenvironments, the immune system and cancer survival;Strausberg;Genome Biol.,2005

2. Oncolytic virotherapy;Russell;Nat. Biotechnol.,2012

3. From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer;Ilkow;PLoS Pathog.,2014

4. Snapshot: cancer immunotherapy with oncolytic viruses;Gujar;Cell,2019

5. Measles virus for cancer therapy;Russell;Curr. Top. Microbiol. Immunol.,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VESICULOVIRUSES AS A TOOL OF BIOTECHNOLOGY;Biotechnologia Acta;2023-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP